Daniel M. Gruener, M.D.January 21, 2020

FDA 483 - Daniel M. Gruener, M.D. - January 21, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Daniel M. Gruener, M.D.

Record Details

An FDA inspection of Daniel M. Gruener, M.D. in Saint Louis, MO, identified a significant deficiency related to the maintenance of informed consent documents. The firm failed to prepare or maintain adequate and accurate case histories, specifically by not retaining original informed consent forms for multiple subjects participating in a clinical study. This finding highlights concerns regarding recordkeeping and the protection of human subjects in clinical research.

Company: Daniel M. Gruener, M.D.
Inspection Date: January 21, 2020
Product Type: Drugs
Office: Division of Human and Animal Food Operations - West II
Person: Karen M. Montgomery (issuing_officer)

Open in Dashboard

ID · d6b4a6ba-2b49-4fb6-8650-da7f93fba2e1